These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16978240)

  • 1. Venlafaxine-induced ecchymoses and impaired platelet aggregation.
    Sarma A; Horne MK
    Eur J Haematol; 2006 Dec; 77(6):533-7. PubMed ID: 16978240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat.
    Béïque J; de Montigny C; Blier P; Debonnel G
    Neuropharmacology; 2000 Jul; 39(10):1813-22. PubMed ID: 10884562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs.
    Bismuth-Evenzal Y; Gonopolsky Y; Gurwitz D; Iancu I; Weizman A; Rehavi M
    J Affect Disord; 2012 Jan; 136(1-2):99-103. PubMed ID: 21893349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin toxicity with therapeutic doses of dexamphetamine and venlafaxine.
    Prior FH; Isbister GK; Dawson AH; Whyte IM
    Med J Aust; 2002 Mar; 176(5):240-1. PubMed ID: 11999244
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibitory effect of melatonin on platelet activation induced by collagen and arachidonic acid.
    Kornblihtt LI; Finocchiaro L; Molinas FC
    J Pineal Res; 1993 May; 14(4):184-91. PubMed ID: 8345446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenelzine and venlafaxine interaction.
    Phillips SD; Ringo P
    Am J Psychiatry; 1995 Sep; 152(9):1400-1. PubMed ID: 7653704
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro effects of serotonin and noradrenaline reuptake inhibitors on human platelet adhesion and coagulation.
    Hallbäck I; Hägg S; Eriksson AC; Whiss PA
    Pharmacol Rep; 2012; 64(4):979-83. PubMed ID: 23087151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
    Béïque J; de Montigny C; Blier P; Debonnel G
    Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [St. Johns wort-venlafaxine interaction].
    Prost N; Tichadou L; Rodor F; Nguyen N; David JM; Jean-Pastor MJ
    Presse Med; 2000 Jul; 29(23):1285-6. PubMed ID: 10923134
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence of the dual mechanisms of action of venlafaxine.
    Harvey AT; Rudolph RL; Preskorn SH
    Arch Gen Psychiatry; 2000 May; 57(5):503-9. PubMed ID: 10807491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venlafaxine and bilateral acute angle closure glaucoma.
    Ng B; Sanbrook GM; Malouf AJ; Agarwal SA
    Med J Aust; 2002 Mar; 176(5):241. PubMed ID: 11999245
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation.
    Berger JS; Becker RC; Kuhn C; Helms MJ; Ortel TL; Williams R
    Thromb Haemost; 2013 Jan; 109(1):85-92. PubMed ID: 23223800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Venlafaxine on Platelet Count and Activity-Case Report and Narrative Review.
    Smolarczyk-Kosowska J; Kosowski M; Kunert Ł; Filipczyk K; Wojciechowski M; Piegza M; Gorczyca P; Okopień B; Pudlo R
    Medicina (Kaunas); 2022 Apr; 58(5):. PubMed ID: 35630043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venlafaxine: a 2003 update.
    Gutierrez MA; Stimmel GL; Aiso JY
    Clin Ther; 2003 Aug; 25(8):2138-54. PubMed ID: 14512125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of venlafaxine versus fluoxetine on metabolism of dextromethorphan, a CYP2D6 probe.
    Amchin J; Ereshefsky L; Zarycranski W; Taylor K; Albano D; Klockowski PM
    J Clin Pharmacol; 2001 Apr; 41(4):443-51. PubMed ID: 11304901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential physiological effects of a low dose and high doses of venlafaxine in major depression.
    Debonnel G; Saint-André E; Hébert C; de Montigny C; Lavoie N; Blier P
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):51-61. PubMed ID: 16690006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of C-reactive protein on platelet function. II. Inhibition by CRP of platelet reactivities stimulated by poly-L-lysine, ADP, epinephrine, and collagen.
    Fiedel BA; Gewurz H
    J Immunol; 1976 Oct; 117(4):1073-8. PubMed ID: 977942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
    Augustin BG; Cold JA; Jann MW
    Pharmacotherapy; 1997; 17(3):511-30. PubMed ID: 9165554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyponatremia with venlafaxine.
    Masood GR; Karki SD; Patterson WR
    Ann Pharmacother; 1998 Jan; 32(1):49-51. PubMed ID: 9475820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.